GATA factor TRPS1, a new DNA repair protein, cooperates with reversible PARylation to promote chemoresistance in patients with breast cancer

Jun Zhang,Yatao Chen,Xue Gong,Yongfeng Yang,Yun Gu,Ling Huang,Jianfeng Fu,Menglu Zhao,Yehong Huang,Lulu Li,Wenzhuo Liu,Yajie Wan,Xilin He,Zhifang Ma,Weiyong Zhao,Meng Zhang,Tao Tang,Yuzhi Wang,Jean Paul Thiery,Xiaofeng Zheng,Liming Chen

DOI: https://doi.org/10.1016/j.jbc.2024.107780

Abstract:Resistance to DNA-damaging agents is a major unsolved challenge for breast cancer patients undergoing chemotherapy. Here, we show that elevated expression of transcriptional repressor GATA binding 1 (TRPS1) is associated with lower drug sensitivity, reduced response rate, and poor prognosis in chemotherapy-treated breast cancer patients. Mechanistically, elevated TRPS1 expression promotes hyperactivity of DNA damage repair (DDR) in breast cancer cells. We provide evidence that TRPS1 dynamically localizes to DNA breaks in a Ku70-and Ku80-dependent manner and that TRPS1 is a new member of the DDR protein family. We also discover that the dynamics of TRPS1 assembly at DNA breaks is regulated by its reversible PARylation in the DDR, and that mutations of the PARylation sites on TRPS1 lead to increased sensitivity to chemotherapeutic drugs. Taken together, our findings provide new mechanistic insights into the DDR and chemoresistance in breast cancer patients and identify TRPS1 as a critical DDR protein. TRPS1 may also be considered as a target to improve chemo-sensitization strategies and, consequently, clinical outcomes for breast cancer patients.